KYTX
Kyverna Therapeutics, Inc.
+0.15 (+2.17%)7.05USD206K成交股數436M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-11下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 0.00 |
| 近 180 天 淨額 | 0.00 |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-27 | 05-29 | Aktar Mert | Director | A 獲配股票 | 5.1K | – | – | 21.7K | SEC |
| 2026-05-27 | 05-29 | Shaw Christi | Executive Chairperson | F 繳稅扣股 | 4.2K | 8.59 | 36K | 66.7K | SEC |
| 2026-05-27 | 05-29 | SEIDENBERG BETH C | Director | A 獲配股票 | 5.1K | – | – | 21.7K | SEC |
| 2026-05-27 | 05-29 | Cohen Fred E | Director | A 獲配股票 | 5.1K | – | – | 21.7K | SEC |
| 2026-05-27 | 05-29 | CLARK IAN T | Director | A 獲配股票 | 5.1K | – | – | 21.7K | SEC |
| 2026-03-13 | 03-17 | Biddle Warner Weston | Chief Executive Officer | A 獲配股票 | 58.0K | – | – | 58.0K | SEC |
| 2026-03-13 | 03-17 | GRASSO MARC | Chief Financial Officer | A 獲配股票 | 10.0K | – | – | 10.0K | SEC |
| 2026-03-13 | 03-17 | GEHCHAN NAJI | See Remarks | A 獲配股票 | 18.0K | – | – | 18.0K | SEC |
| 2026-02-24 | 03-04 | Miller Andrew Craig | Director | A 獲配股票 | 11.0K | – | – | 11.0K | SEC |
| 2026-02-24 | 02-26 | Emany Sravan Kumar | Director | A 獲配股票 | 11.0K | – | – | 11.0K | SEC |
| 2026-01-12 | 01-14 | Shaw Christi | Executive Chairperson | A 獲配股票 | 30.0K | – | – | 46.6K | SEC |
| 2026-01-12 | 01-14 | Shaw Christi | Executive Chairperson | A 獲配股票 | 24.3K | – | – | 70.9K | SEC |
| 2025-12-18 | 12-22 | Westlake BioPartners Fund I, L.P. | TenPercentOwner | P 公開市場買進 | 133K | 7.50 | 1,000K | 869K | SEC |
| 2025-12-18 | 12-22 | Westlake BioPartners Opportunity GP I, LLC | TenPercentOwner | P 公開市場買進 | 133K | 7.50 | 1,000K | 869K | SEC |
| 2025-12-18 | 12-22 | Westlake BioPartners Opportunity Fund I, L.P. | TenPercentOwner | P 公開市場買進 | 133K | 7.50 | 1,000K | 869K | SEC |
| 2025-12-18 | 12-22 | Westlake BioPartners GP I, LLC | TenPercentOwner | P 公開市場買進 | 133K | 7.50 | 1,000K | 869K | SEC |
| 2025-12-18 | 12-22 | SEIDENBERG BETH C | Director | P 公開市場買進 | 133K | 7.50 | 1,000K | 869K | SEC |
| 2025-12-15 | 12-17 | Walker Karen Marie | Chief Technology Officer | M 選擇權執行 | 24.0K | 4.83 | 116K | 46.6K | SEC |
| 2025-12-15 | 12-17 | Walker Karen Marie | Chief Technology Officer | S 公開市場賣出(10b5-1) | 24.0K | 12.20 | 293K | 22.6K | SEC |
| 2025-05-29 | 06-02 | Cohen Fred E | Director,TenPercentOwner | A 獲配股票 | 16.6K | – | – | 16.6K | SEC |
| 2025-05-29 | 06-02 | CLARK IAN T | Director | A 獲配股票 | 16.6K | – | – | 16.6K | SEC |
| 2025-05-29 | 06-02 | Aktar Mert | Director | A 獲配股票 | 16.6K | – | – | 16.6K | SEC |
| 2025-05-29 | 06-02 | SPIEGELMAN DANIEL K | Director | A 獲配股票 | 16.6K | – | – | 16.6K | SEC |
| 2025-05-29 | 06-02 | SEIDENBERG BETH C | Director,TenPercentOwner | A 獲配股票 | 16.6K | – | – | 16.6K | SEC |
| 2025-05-29 | 06-02 | Shaw Christi | Director | A 獲配股票 | 16.6K | – | – | 16.6K | SEC |
| 2025-04-11 | 04-15 | Walker Karen Marie | Chief Technology Officer | A 獲配股票 | 13.0K | – | – | 22.6K | SEC |
| 2025-04-11 | 04-15 | Jones Ryan Alexander | Chief Financial Officer | A 獲配股票 | 12.0K | – | – | 56.0K | SEC |
| 2024-06-06 | 06-10 | Walker Karen Marie | Chief Technology Officer | M 選擇權執行 | 9.6K | 4.42 | 43K | 9.6K | SEC |
| 2024-05-28 | 05-29 | Jones Ryan Alexander | Chief Financial Officer | M 選擇權執行 | 10.9K | 0.73 | 8K | 36.8K | SEC |
| 2024-05-28 | 05-29 | Jones Ryan Alexander | Chief Financial Officer | M 選擇權執行 | 7.1K | 0.73 | 5K | 44.0K | SEC |
| 2024-02-12 | 02-14 | Bain Capital Life Sciences Investors, LLC | TenPercentOwner | C 轉換 | 2.7M | – | – | 2.7M | SEC |
| 2024-02-12 | 02-14 | Bain Capital Life Sciences Investors, LLC | TenPercentOwner | P 公開市場買進 | 450K | 22.00 | 9.9M | 3.2M | SEC |
| 2024-02-12 | 02-14 | Bain Capital Life Sciences Fund III, L.P. | TenPercentOwner | C 轉換 | 2.7M | – | – | 2.7M | SEC |
| 2024-02-12 | 02-14 | Bain Capital Life Sciences Fund III, L.P. | TenPercentOwner | P 公開市場買進 | 450K | 22.00 | 9.9M | 3.2M | SEC |
| 2024-02-12 | 02-14 | Bain Capital Life Sciences Opportunities III, LP | TenPercentOwner | C 轉換 | 2.7M | – | – | 2.7M | SEC |
| 2024-02-12 | 02-14 | Bain Capital Life Sciences Opportunities III, LP | TenPercentOwner | P 公開市場買進 | 450K | 22.00 | 9.9M | 3.2M | SEC |
| 2024-02-12 | 02-14 | Bain Capital Life Sciences III General Partner, LLC | TenPercentOwner | C 轉換 | 2.7M | – | – | 2.7M | SEC |
| 2024-02-12 | 02-14 | Bain Capital Life Sciences III General Partner, LLC | TenPercentOwner | P 公開市場買進 | 450K | 22.00 | 9.9M | 3.2M | SEC |
| 2024-02-12 | 02-14 | Bain Capital Life Sciences Opportunities III GP, LLC | TenPercentOwner | C 轉換 | 2.7M | – | – | 2.7M | SEC |
| 2024-02-12 | 02-14 | Bain Capital Life Sciences Opportunities III GP, LLC | TenPercentOwner | P 公開市場買進 | 450K | 22.00 | 9.9M | 3.2M | SEC |
| 2024-02-12 | 02-14 | SEIDENBERG BETH C | Director,TenPercentOwner | C 轉換 | 3.8M | – | – | 3.8M | SEC |
| 2024-02-12 | 02-14 | SEIDENBERG BETH C | Director,TenPercentOwner | C 轉換 | 736K | – | – | 736K | SEC |
| 2024-02-12 | 02-14 | Cohen Fred E | Director,TenPercentOwner | C 轉換 | 4.5M | – | – | 4.5M | SEC |
| 2024-02-12 | 02-14 | Vida Ventures, LLC | TenPercentOwner | C 轉換 | 4.5M | – | – | 4.5M | SEC |
| 2024-02-12 | 02-14 | Vida Ventures, LLC | TenPercentOwner | P 公開市場買進 | 253K | 22.00 | 5.6M | 253K | SEC |
| 2024-02-12 | 02-14 | Vida Ventures, LLC | TenPercentOwner | P 公開市場買進 | 583 | 22.00 | 13K | 583 | SEC |
| 2024-02-12 | 02-14 | Vida Ventures GP III, L.L.C. | TenPercentOwner | C 轉換 | 4.5M | – | – | 4.5M | SEC |
| 2024-02-12 | 02-14 | Vida Ventures GP III, L.L.C. | TenPercentOwner | P 公開市場買進 | 253K | 22.00 | 5.6M | 253K | SEC |
| 2024-02-12 | 02-14 | Vida Ventures GP III, L.L.C. | TenPercentOwner | P 公開市場買進 | 583 | 22.00 | 13K | 583 | SEC |
| 2024-02-12 | 02-14 | Vida Ventures III-A, L.P. | TenPercentOwner | C 轉換 | 4.5M | – | – | 4.5M | SEC |
| 2024-02-12 | 02-14 | Vida Ventures III-A, L.P. | TenPercentOwner | P 公開市場買進 | 253K | 22.00 | 5.6M | 253K | SEC |
| 2024-02-12 | 02-14 | Vida Ventures III-A, L.P. | TenPercentOwner | P 公開市場買進 | 583 | 22.00 | 13K | 583 | SEC |
| 2024-02-12 | 02-14 | Vida Ventures III, L.P. | TenPercentOwner | C 轉換 | 4.5M | – | – | 4.5M | SEC |
| 2024-02-12 | 02-14 | Vida Ventures III, L.P. | TenPercentOwner | P 公開市場買進 | 253K | 22.00 | 5.6M | 253K | SEC |
| 2024-02-12 | 02-14 | Vida Ventures III, L.P. | TenPercentOwner | P 公開市場買進 | 583 | 22.00 | 13K | 583 | SEC |
| 2024-02-12 | 02-14 | Harper Sean E | TenPercentOwner | C 轉換 | 3.8M | – | – | 3.8M | SEC |
| 2024-02-12 | 02-14 | Harper Sean E | TenPercentOwner | C 轉換 | 736K | – | – | 736K | SEC |
| 2024-02-12 | 02-14 | Westlake BioPartners Fund I, L.P. | TenPercentOwner | C 轉換 | 3.8M | – | – | 3.8M | SEC |
| 2024-02-12 | 02-14 | Westlake BioPartners Fund I, L.P. | TenPercentOwner | C 轉換 | 736K | – | – | 736K | SEC |
| 2024-02-12 | 02-14 | Westlake BioPartners Opportunity GP I, LLC | TenPercentOwner | C 轉換 | 3.8M | – | – | 3.8M | SEC |
| 2024-02-12 | 02-14 | Westlake BioPartners Opportunity GP I, LLC | TenPercentOwner | C 轉換 | 736K | – | – | 736K | SEC |
| 2024-02-12 | 02-14 | Westlake BioPartners Opportunity Fund I, L.P. | TenPercentOwner | C 轉換 | 3.8M | – | – | 3.8M | SEC |
| 2024-02-12 | 02-14 | Westlake BioPartners Opportunity Fund I, L.P. | TenPercentOwner | C 轉換 | 736K | – | – | 736K | SEC |
| 2024-02-12 | 02-14 | Westlake BioPartners GP I, LLC | TenPercentOwner | C 轉換 | 3.8M | – | – | 3.8M | SEC |
| 2024-02-12 | 02-14 | Westlake BioPartners GP I, LLC | TenPercentOwner | C 轉換 | 736K | – | – | 736K | SEC |
| 2024-02-12 | 02-13 | GILEAD SCIENCES, INC. | TenPercentOwner | C 轉換 | 3.2M | – | – | 3.2M | SEC |
| 2024-02-12 | 02-13 | GILEAD SCIENCES, INC. | TenPercentOwner | P 公開市場買進 | 910K | 22.00 | 20.0M | 4.1M | SEC |
| 2024-02-12 | 02-12 | Rubin Michael P. | Other | C 轉換 | 2.8M | – | – | 2.8M | SEC |
| 2024-02-12 | 02-12 | Rubin Michael P. | Other | P 公開市場買進 | 450K | 22.00 | 9.9M | 450K | SEC |
| 2024-02-12 | 02-12 | Northpond Ventures III, LP | Other | C 轉換 | 2.8M | – | – | 2.8M | SEC |
| 2024-02-12 | 02-12 | Northpond Ventures III, LP | Other | P 公開市場買進 | 450K | 22.00 | 9.9M | 450K | SEC |
| 2024-02-12 | 02-12 | Northpond Ventures III GP, LLC | Other | C 轉換 | 2.8M | – | – | 2.8M | SEC |
| 2024-02-12 | 02-12 | Northpond Ventures III GP, LLC | Other | P 公開市場買進 | 450K | 22.00 | 9.9M | 450K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| GordonMD Global Investments LP | 4.2M | 37.8M | 新進 | 新進 |
| GILEAD SCIENCES, INC. | 4.1M | 36.8M | 新進 | 新進 |
| BlackRock, Inc. | 3.1M | 27.9M | 新進 | 新進 |
| Bain Capital Life Sciences Investors, LLC | 2.9M | 25.7M | 新進 | 新進 |
| AIGH Capital Management LLC | 2.8M | 24.9M | 新進 | 新進 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 2.0M | 17.8M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.9M | 16.9M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.0M | 9.4M | 新進 | 新進 |
| Insight Holdings Group, LLC | 989K | 8.8M | 新進 | 新進 |
| MORGAN STANLEY | 982K | 8.8M | 新進 | 新進 |
| STATE STREET CORP | 982K | 8.8M | 新進 | 新進 |
| Propel Bio Management, LLC | 883K | 7.9M | 新進 | 新進 |
| Woodline Partners LP | 845K | 7.5M | 新進 | 新進 |
| 千禧 MILLENNIUM MANAGEMENT LLC | 640K | 5.7M | 新進 | 新進 |
| MBB PUBLIC MARKETS I LLC | 614K | 5.5M | 新進 | 新進 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 500K | 4.5M | 新進 | 新進 |
| 德劭 D. E. Shaw & Co., Inc. | 469K | 4.2M | 新進 | 新進 |
| WELLS FARGO & COMPANY/MN | 373K | 3.3M | 新進 | 新進 |
| UBS Group AG | 366K | 3.3M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 335K | 3.0M | 新進 | 新進 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 334K | 3.0M | 新進 | 新進 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 320K | 2.8M | 新進 | 新進 |
| NORTHERN TRUST CORP | 315K | 2.8M | 新進 | 新進 |
| BNP PARIBAS FINANCIAL MARKETS | 311K | 2.8M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 282K | 2.5M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 120 +9 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 120 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 37.6M · 60.8% |
| 合計季末市值 | 324M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 8.5M |
|---|---|
| 與上期比 | -0.5% |
| 佔流通股數 | 13.67% |
| 日均成交量 | 685K |
| 回補天數 | 12.4 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 8.5M | -0.5% | 13.67% | 685K | 12.4 |
| 2026-08-14 | 8.5M | +3.9% | 13.74% | 637K | 13.3 |
| 2026-07-31 | 8.2M | +4.2% | 13.22% | 937K | 8.7 |
| 2026-07-15 | 7.8M | +8.7% | 12.69% | 1.3M | 6.1 |
| 2026-06-30 | 7.2M | +18.9% | 11.67% | 1.6M | 4.6 |
| 2026-06-15 | 6.1M | +5.8% | 9.81% | 721K | 8.4 |
| 2026-05-29 | 5.7M | +8.6% | 9.28% | 838K | 6.9 |
| 2026-05-15 | 5.3M | +2.4% | 8.54% | 859K | 6.2 |
| 2026-04-30 | 5.2M | +22.0% | 8.35% | 1.7M | 3.0 |
| 2026-04-15 | 4.2M | +0.5% | 6.84% | 678K | 6.2 |
| 2026-03-31 | 4.2M | +0.2% | 6.81% | 684K | 6.2 |
| 2026-03-13 | 4.2M | +0.4% | 6.80% | 669K | 6.3 |
| 2026-02-27 | 4.2M | +6.8% | 6.77% | 440K | 9.5 |
| 2026-02-13 | 3.9M | +12.0% | 6.35% | 653K | 6.0 |
| 2026-01-30 | 3.5M | +2.8% | 5.67% | 984K | 3.6 |
| 2026-01-15 | 3.4M | -4.1% | 5.51% | 972K | 3.5 |
| 2025-12-31 | 3.6M | +1.8% | 5.75% | 3.0M | 1.2 |
| 2025-12-15 | 3.5M | -1.1% | 5.64% | 2.1M | 1.6 |
| 2025-11-28 | 3.5M | +13.5% | 5.71% | 555K | 6.4 |
| 2025-11-14 | 3.1M | +15.3% | 5.03% | 697K | 4.5 |
| 2025-10-31 | 2.7M | +71.0% | 4.36% | 742K | 3.6 |
| 2025-10-15 | 1.6M | +9.0% | 2.55% | 1.1M | 1.5 |
| 2025-09-30 | 1.4M | -10.0% | 2.34% | 614K | 2.4 |
| 2025-09-15 | 1.6M | +19.3% | 2.60% | 270K | 6.0 |
| 2025-08-29 | 1.3M | -14.5% | 2.18% | 275K | 4.9 |
| 2025-08-15 | 1.6M | +4.9% | 2.55% | 281K | 5.6 |